http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113648378-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-532 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
| filingDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113648378-B |
| titleOfInvention | Traditional Chinese medicine compound for treating early stage neocoronary pneumonia and application of traditional Chinese medicine compound for treating respiratory tract infection |
| abstract | The invention discloses a traditional Chinese medicine compound for treating early stage neocoronary pneumonia and application of the traditional Chinese medicine compound for treating respiratory tract infection, wherein the traditional Chinese medicine compound comprises the following traditional Chinese medicine raw materials in parts by weight: 5-7 parts of radix tetrastigme, 9-11 parts of schizonepeta, 8-10 parts of divaricate saposhnikovia root, 14-16 parts of fructus forsythiae, 8-10 parts of honeysuckle, 8-10 parts of radix peucedani, 8-10 parts of cablin potchouli herb, 8-10 parts of rhizoma atractylodis (fried), 29-31 parts of rhizoma phragmitis, 5-7 parts of platycodon grandiflorum and 4-6 parts of liquorice. The Chinese herbal compound of the invention has better inhibition effect on SARS-CoV-2 replication in cells, and clinical application proves that the Chinese herbal compound of the invention has the effective rate of 86.6 percent on the clinical curative effect of new coronary pneumonia, the clinical cure rate of 57.3 percent, obvious improvement on breast images and new drug selection for early stage of coronary pneumonia; moreover, the traditional Chinese medicine compound can also be used for preparing medicines for treating respiratory tract infection, influenza, viral pneumonia and exogenous febrile disease, and has the advantages of quick response, high cure rate, low cost, safety, convenience and no toxic or side effect. |
| priorityDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.